When Nothing Changes.
Why well-resourced innovation functions still fail to produce ventures?
The executive sponsor thanks the teams. The head of innovation circulates the highlights to the leadership team. The internal newsletter runs a feature. And, the LinkedIn post gets 200 likes.
Six weeks later, nothing has structurally changed.
No capital moved. No initiative received dedicated resourcing. No decision rights shifted. The teams are still operating on the same budgets, with the same headcount, inside the same reporting lines.
The showcase was a success. The innovation program is active, but nothing has happened to change the trajectory of a single venture within the organisation.
This is not a failure of effort or intent. It is a structural condition. It is innovation theatre.
Activity without consequence
Innovation theatre occurs when innovation functions are designed around activity metrics rather than execution outcomes.
The activity is real. Ideas are generated, workshops are held, pilots are built, and teams prepare status updates on schedule. But the structural indicators of execution remain unchanged.
No additional capital has been reallocated, authority and decision rights have not shifted, and scope has not narrowed. In summary, nothing has stopped or significantly changed to double down on the bets made.
The innovation function exists inside the organisation’s communication layer, presentations, updates, reports, showcases, but outside its decision layer. It does not influence how budgets are constructed, how resources are deployed, or how strategic priorities are adjusted.
Steve Blank identified this pattern in Harvard Business Review in 2019, describing how organisations adopt innovation activities, hackathons, workshops, and design sprints, that produce the appearance of innovation without its structural consequences. He distinguished between organisational theatre, innovation theatre, and process theatre. What he named as a behavioural tendency is, more precisely, a governance design problem. The activities are real. The structural authority to act on what they produce is not.
This creates a peculiar dynamic. The function appears healthy on the surface. Internally, the teams running initiatives often sense that something is missing, but struggle to articulate exactly what.
What is missing is execution authority.
Innovation without execution authority is not a program, nor a priority. It is a marketing newsletter.
Why does the system reward appearance?
Innovation mandates are often issued by leadership but not structurally empowered. A CEO or board declares that innovation is a strategic priority. This leads to the formation of a team or teams and the issuance of mandates, but the organisation’s decision architecture does not change to accommodate it.
The innovation operation receives permission to explore, but not the authority to execute. It can generate ideas, run experiments, and build prototypes. But it cannot reallocate capital, reassign talent, narrow the portfolio, or stop initiatives that are not working.
This is not a personality problem. It is an incentive and governance design problem.
Innovation teams are typically measured on:
Number of ideas generated or submitted.
Number of workshops and hackathons were conducted.
Pilots launched, or partners engaged.
Presentations delivered to leadership.
Internal participation and engagement rates.
Progress is reported as stakeholder alignment, strategic conversations, or engagement quality, measures that are difficult to challenge precisely because they are difficult to define.
These are activity metrics that measure the function’s performance, not the performance of the ventures it pursues.
Execution metrics look different and operate on two levels. The first level measures whether the system has reorganised. Whether signals actually changed how the organisation behaves:
Capital reallocated based on evidence.
Initiatives stopped when signals decayed.
Decision rights assigned to venture leads.
Resources concentrated on compounding signals.
Scope narrowed as conviction increased.
The second level measures whether that reorganisation produced results:
Ventures that generated measurable commercial outcomes, revenue, customers acquired, contracts signed, or return on invested capital.
Time from validated signal to resourced commitment, the speed at which the system converts evidence into structural action.
Most innovation functions track neither level. Some may track the first without the second, which creates structural movement without accountability for outcomes. The combination is what matters; did the system reorganise, and did that reorganisation produce a venture, regardless of whether the method used was build, invest or partner, worth the resources it consumed?
In most corporate innovation functions, no one is measured on either. And what is not measured is rarely prioritised.
The result is a system that rewards the appearance of innovation without requiring its structural consequences or its commercial outcomes.
A Structural Disconnect
There is a pattern I have seen repeated across large organisations, in financial services, resources, government-linked enterprises, and increasingly inside universities, establishing venture mandates.
An innovation team identifies a genuine opportunity with promising signals identified early. The team is motivated, and the work is credible. But when the initiative reaches the point where it needs structural support, dedicated capital, decision authority, and talent reallocation, the organisation does not respond.
Not because leadership disagrees or the evidence is weak, but because the system is not designed to convert innovation signals into structural decisions when consequences start to matter, to the executive sponsors and the organisation broadly.
The triple mandate.
Corporate innovation functions are often expected to operate across multiple roles simultaneously. In a startup ecosystem, these functions are typically separated: capital allocators decide where funding flows, venture builders build ventures, and operators execute under uncertainty. Within a corporate innovation function, one team often handles all three. They allocate “budgetted” capital across a portfolio of initiatives, build internal experiments/ventures, and are expected to deliver execution discipline that turns signals into structural commitment.
That triple mandate creates a specific governance tension. When the same team is responsible for funding decisions (within a stated risk tolerance), exploration venture creation, and execution oversight, the execution layer almost always suffers. It is the least visible of the three roles and the least rewarded. Capital allocation decisions get board attention. New ventures get showcased. Execution discipline, narrowing scope, stopping initiatives, and reallocating resources happen quietly, if at all.
Given the matrixed structure of most large organisations, this problem compounds. Even where innovation teams have capable people and clear intent, the decisions required to convert a validated signal into a resourced venture do not rest solely within the innovation function. They are distributed across the organisation.
Capital reallocation requires finance and strategic planning approval. Governance sign-off involves a separate committee with its own cadence and risk appetite. Legal review follows its own timeline. Risk assessment introduces additional conditions. Procurement, if an external partner or vendor is involved, adds another layer. Each of these functions operates with different incentives, different timelines, and critically, no shared accountability for venture outcomes.
The innovation team may have identified the signal, built the business case, and demonstrated early traction. But the decisions required to act on that evidence are scattered across five or six organisational functions, none of which are measured on whether the venture succeeds. Each can slow or stop progress, as none has the mandate to accelerate it.
This is not bureaucracy for its own sake. These functions exist for legitimate reasons: risk management, capital stewardship, and legal compliance. The problem is that they were designed to govern established business operations, not to coordinate around new-venture timelines for unexpected, uncertain opportunities where speed and evidence-based resource allocation are critical.
Budget cycles are annual, and headcount is planned and allocated twelve months in advance. Governance committees meet quarterly, and legal review queues are measured in weeks. The venture’s signal is compounding now.
By the time the system responds, the window may have narrowed or closed.
And so the innovation team continues to operate in the margin. It can run experiments. It can present results. But it cannot trigger the structural changes that would turn a promising initiative into a funded venture with execution authority, because those changes require coordination across functions that were never designed to move at venture speed.
This is the structural disconnect at the heart of innovation theatre. The front end of innovation, ideation, exploration, and experimentation, is well resourced and largely contained within the innovation function. The back end, commitment, resource movement, and governance escalation are fragmented across the organisation, operating on fundamentally different rhythms.
The evidence supports this. McKinsey has reported that nearly two-thirds of organisations remain stuck in pilot mode, unable to scale projects across the enterprise. The framing is often about technology adoption or digital transformation. Still, the structural pattern is identical: organisations that are effective at launching experiments but are unable to convert them into scaled execution. The bottleneck is not the front end. It is the transition from exploration to structural commitment, a transition that requires organisational coordination, which the system was not built to handle.
The front end of corporate innovation is well built and largely self-contained. The back end, where signals become structural commitment, is fragmented across the organisation. That is where ventures stall.
The Quiet Cost
Innovation theatre does not produce dramatic failures. That is part of why it persists.
There is no crisis point, no public failure, no sudden loss. The function continues, and updates are positive. Activity is sustained, and from the outside, everything appears functional. The cost is quieter and cumulative.
BCG’s 2024 Most Innovative Companies report quantified this gap. Eighty-three per cent of senior executives now rank innovation among their top three priorities. Yet only 3 per cent of companies qualified as innovation-ready, a sharp decline from 20 per cent just 2 years earlier. The aspiration has been rising, but the ability to execute has been falling. A lack of ideas or investment does not explain that divergence. It is explained by the structural gap between innovation activity and the authority to execute.
Talent attrition is the earliest signal. High-capability operators inside innovation teams eventually recognise the structural ceiling. They leave, not because they are disengaged, but because they have learned that the system will not convert their work into execution. The organisation loses its most execution-oriented people first.
Organisational credibility erodes next. When successive cohorts of initiatives fail to produce structural outcomes, leadership begins to question the function’s value. External credibility follows. Startup founders and partners who engage with corporate venturing functions learn quickly which organisations have execution authority and which are performing the function without it. In ecosystems like Australia, where the corporate innovation community is relatively concentrated, this reputation moves fast.
The cumulative cost is not the money spent on the function. It is the ventures that were not built, the talent that left, and the organisational patience that is consumed without producing structural change.
From Communications to Execution
The shift is not about running fewer initiatives or generating fewer ideas. Exploration has genuine value. The shift is about what the organisation measures and what authority the innovation function holds.
The diagnostic question is simple:
What capital, authority, or resources moved because of this initiative?
If the answer is nothing, the function produced content, not execution. The initiative may have generated learning, relationships, or internal visibility. Those are not worthless, but they are not venture creation.
For corporate innovation functions to produce ventures rather than activity, three conditions need to be present:
Execution authority must exist within the function. Someone within the innovation function must be able to recommend capital reallocation, talent movement, or scope narrowing. That recommendation must connect to a decision-maker who can act on it within the venture’s timeline, not the organisation’s planning cycle.
Measurement must shift from activity to structural consequence. If the function is measured by how many ideas it generates, it will generate ideas. If it is measured by how many initiatives received dedicated resources, had their scope narrowed, or were stopped based on evidence, it will produce execution discipline.
The stop authority must be safe. Innovation theatre persists partly because stopping is politically expensive. Ending a pilot, deprioritising an initiative, or narrowing the portfolio creates visibility. If that visibility is punished rather than rewarded, the rational response is to continue everything. The system must make stopping as structurally safe as starting.
Let’s Execute
This is not a strategy exercise. It is a structural audit you can run this week.
Answer these five questions about your innovation function. Answer them honestly, not optimistically.
1. Does anyone inside the innovation function have the authority to recommend resource reallocation?
Not in theory. In practice. Has it happened in the last twelve months? If the answer is no, the function operates inside the communication layer, not the decision layer.
2. When was the last time an initiative was stopped based on evidence?
Not paused. Not “deprioritised.” Stopped. If nothing has been stopped, the function lacks kill discipline. Every active initiative is consuming resources that could be concentrated on stronger signals.
3. What changed structurally after your last showcase or review?
Did capital move? Did headcount shift? Did decision rights change? If the answer to all three is no, the review is a communication event, not a decision event.
4. How is the innovation function measured?
List the metrics. Separate them into two categories: activity metrics (ideas generated, workshops held, pilots launched) and execution metrics (capital reallocated, initiatives stopped, resources concentrated). Count each column. The ratio tells you what the function is designed to produce.
5. If your strongest initiative needed dedicated resources next month, could the system deliver them?
Not next budget cycle. Next month. If the answer is no, the organisation’s resource clock runs on a fundamentally different cadence from its venture clock. That mismatch is where promising initiatives stall.
If three or more of these answers reveal structural gaps, the function is not yet designed to produce ventures. It is designed to produce activity.
That is not a judgement of the people running it. It is a description of the system they operate within.
A Closing Thought
Corporate innovation functions inside large organisations are often staffed by capable people doing credible work under significant constraints. The problem is rarely effort, intent, or even the quality of ideas.
The problem is that the system around them was not designed to convert their work into structural change.
Execution authority is not a reward for proving yourself. It is a precondition for the production of ventures. Without it, even the strongest signals remain observations rather than decisions.
Ideas do not scale. Execution does. And execution begins when something in the structure actually moves.
What’s coming next? Execution authority is one structural gap. But even when functions have some authority, individual initiatives can persist long past the point where signals justify continuation. The next issue examines the most common expression of this: the corporate pilot that cannot die. Not because it is succeeding, but because stopping it is structurally harder than continuing.
This article draws on patterns observed across corporate venturing and innovation functions, startups, venture studios, and university commercialisation environments. Individual context matters.